SteriPack announced that United Kingdom-based private equity firm Inflexion Private Equity Partners led a buyout of the company.
According to a news release, the strategic partnership poises SteriPack — which provides holistic and integrated product life-cycle management services — for accelerated growth, geographical expansion and an enhanced service offering to better support current and future customers.
Funding from the buyout will support the business’ efforts to scale globally as it benefits from market growth and further international expansion opportunities. The company added that it is well placed to undertake further acquisitions with the support of Inflexion.
Florencia Kassai, partner and head of Inflexion’s buyout fund, said in the release that SteriPack is an “extremely successful niche market player” and the company is excited to bring its experience to help management accelerate growth.
“We’re very proud of our strong growth record and are keen to build on it to take SteriPack even further as we become even more valued partners to our customers through expansion of our capabilities and geographic footprint,” SteriPack CEO Andrew McLean said. “Inflexion’s presence in our core markets of Europe, Asia and the US as well as its extensive M&A experience make it the ideal partner to support our future international growth.”
